Zobrazeno 1 - 10 of 121 pro vyhledávání: '"D J, PERRY"'
1
Laboratory assay measurement of modified clotting factor concentrates: a review of the literature and recommendations for practice
Autor: Guy Young, D. J. Perry
Publikováno v: Journal of Thrombosis and Haemostasis. 17:567-573
Over the past several years, novel modified clotting factor concentrates (CFCs) have been introduced into practice and are now widely prescribed in the countries where they are licensed. These products allow for less frequent infusions of CFC, thereb
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52808004754250350ae46468f4d96932
https://doi.org/10.1111/jth.14394
Zobrazit plný text záznamu
2
Adenovirus‐associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus‐associated virus vector–serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A
Autor: John Pasi, Desmond Creagh, D. J. Perry, Ruth Pink, Gregory M. Hayes, Amanda Clark, Sylvia Fong, Sophia Stanford, Gillian C. Lowe, Savita Rangarajan, Kandiah Chandrakumaran, Nicola Curry
Publikováno v: Research and Practice in Thrombosis and Haemostasis
Background Current treatment for severe hemophilia A is replacement of deficient factor. Although replacement therapy has improved life expectancy and quality, limitations include frequent infusions and high costs. Gene therapy is a potential alterna
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2476659e13f941e87501a741ca0983e5
https://doi.org/10.1002/rth2.12177
Zobrazit plný text záznamu
3
Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variants
Autor: Daniel Duarte, Mariana Bonduel, Sri V V Deevi, Kathleen Stirrups, Paolo Gresele, David Allsup, Rutendo Mapeta, Jonathan Stephens, Tadbir K. Bariana, Kathleen Freson, Nihr BioResource, Ernest Turro, Kim Elliott, Nicola Curry, David Keeling, D. J. Perry, Kate Downes, Carolyn M. Millar, Luigi Grassi, Keith Gomez, Nora Butta, Ilenia Simeoni, Emanuela Falcinelli, Peter William Collins, Michele P. Lambert, Christopher J. Penkett, Loredana Bury, John K. Wu, Nick Gleadall, Karina Althaus, Daniel Greene, Bruce Furie, Willem H. Ouwehand, Rachel Linger, Sarah K Westbury, Karyn Megy, Sarah Mangles
Publikováno v: Human Mutation
Bury, L, Megy, K, Stephens, J C, Grassi, L, Greene, D, Gleadall, N, Althaus, K, Allsup, D, Bariana, T, Bonduel, M, Butta, N, Collins, P, Curry, N, Deevi, S V V, Downes, K, Duarte, D, Elliott, K, Falcinelli, E, Furie, B, Keeling, D, Lambert, M P, Linger, R, Mangles, S, Mapeta, R, Millar, C M, Penkett, C J, Perry, D J, Stirrups, K, Turro, E, Westbury, S K, Wu, J, Gomez, K, Freson, K, Ouwehand, W H & Gresele, P & Simeoni, I 2019, ' Next-generation sequencing for the diagnosis of MYH9-RD : predicting pathogenic variants ', Human Mutation . https://doi.org/10.1002/humu.23927
Bury, L, Megy, K, Stephens, J C, Grassi, L, Greene, D, Gleadall, N, Althaus, K, Allsup, D, Bariana, T K, Bonduel, M, Butta, N V, Collins, P, Curry, N, Deevi, S V V, Downes, K, Duarte, D, Elliott, K, Falcinelli, E, Furie, B, Keeling, D, Lambert, M P, Linger, R, Mangles, S, Mapeta, R, Millar, C M, Penkett, C, Perry, D J, Stirrups, K E, Turro, E, Westbury, S K, Wu, J, Bioresource, N, Gomez, K, Freson, K, Ouwehand, W H, Gresele, P, Simeoni, I, Williamson, C & Dixon, P 2020, ' Next-generation sequencing for the diagnosis of MYH9 -RD: Predicting pathogenic variants ', Human Mutation, vol. 41, no. 1, pp. 277-290 . https://doi.org/10.1002/humu.23927
The heterogeneous manifestations of MYH9‐related disorder (MYH9‐RD), characterized by macrothrombocytopenia, Döhle‐like inclusion bodies in leukocytes, bleeding of variable severity with, in some cases, ear, eye, kidney, and liver involvement,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b150ff99d83e6e6627c2e3b46c3ed5c
https://lirias.kuleuven.be/handle/123456789/641720
Zobrazit plný text záznamu
5
Long‐term safety and efficacy of recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with haemophilia A
Autor: K. J. Pasi, Johnny Mahlangu, Barbara A. Konkle, Simon A Brown, H. Hanabusa, X Li, Savita Rangarajan, G. Allen, Ingrid Pabinger, Lynda M. Cristiano, Beatrice Nolan, D. J. Perry, R. Liesner, Glenn F. Pierce, Guy Young, Shannon Jackson
Publikováno v: Haemophilia. 22:72-80
Introduction The safety, efficacy and prolonged half-life of recombinant factor VIII Fc fusion protein (rFVIIIFc) in previously treated patients with severe haemophilia A was demonstrated in the phase 3 A-LONG and Kids A-LONG studies. Here, we report
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e85ad2a1ea01d5a1dcd57867838c2a23
https://doi.org/10.1111/hae.12766
Zobrazit plný text záznamu
6
The UK National External Quality Assessment Scheme for Heritable Bleeding Disorders
Autor: Steven Kitchen, D. J. Perry, Ian Jennings, Marian Hill, Tony Cumming, Isobel D. Walker, Anne Goodeve
Publikováno v: Seminars in Thrombosis and Hemostasis. 40:261-268
Molecular genetic analysis of families with hemophilia and other heritable bleeding disorders is a frequently requested laboratory investigation. In the United Kingdom, laboratories undertaking genetic testing must participate in a recognized externa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9079de34f4010973d2eef6a0d36e52a8
https://doi.org/10.1055/s-0034-1365843
Zobrazit plný text záznamu
7
Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A
Autor: Shuanglian Li, Johnny Mahlangu, Pratima Chowdary, Amy D. Shapiro, D. J. Perry, G. Allen, Doris Quon, Glenn F. Pierce, Elisa Tsao, Alison Innes, John Pasi
Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia. 23(3)
Introduction The Phase 3 A-LONG study demonstrated the safety and efficacy of rFVIIIFc for the control and prevention of bleeding episodes in severe haemophilia A. Aim To describe the treatment of bleeding episodes with rFVIIIFc in the A-LONG study.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea001b4c0720c06541d0f8d8cbbfa02
https://pubmed.ncbi.nlm.nih.gov/28220631
Zobrazit plný text záznamu
8
A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies
Autor: Claire Lentaigne, Deborah Whitehorn, Tamam Bakchoul, Tadbir K. Bariana, John Bradley, Anne M. Kelly, Anouck Wijgaerts, Jonathan Stephens, Rémi Favier, Chantal Thys, Marc De Maeyer, Augusto Rendon, Sri V V Deevi, Kathelijne Peerlinck, F. Lucy Raymond, Michele P. Lambert, Kathleen Freson, Michael Laffan, D. J. Perry, Sylvia Richardson, Myrto Kostadima, Andrew D Mumford, Kathleen Stirrups, Christopher J. Penkett, Ernest Turro, Sol Schulman, Ilenia Simeoni, Wendy N. Erber, Willem H. Ouwehand, Keith Gomez, Mary Mathias, Paquita Nurden, Sofia Papadia, Chris Van Geet, Steve Austin, Sarah K Westbury, Daniel Greene, Sofie Ashford, Dominik Selleslag, Christine Wittevrongel, Peter William Collins, Carolyn M. Millar, Antony P. Attwood
Publikováno v: Science Translational Medicine, 8(328):328ra30. American Association for the Advancement of Science
Turro, E, Greene, D, Wijgaerts, A, Thys, C, Lentaigne, C, Bariana, T K, Westbury, S K, Kelly, A M, Selleslag, D, Stephens, J C, Papadia, S, Simeoni, I, Penkett, C J, Ashford, S, Attwood, A, Austin, S, Bakchoul, T, Collins, P, Deevi, S V V, Favier, R, Kostadima, M, Lambert, M P, Mathias, M, Millar, C M, Peerlinck, K, Perry, D J, Schulman, S, Whitehorn, D, Wittevrongel, C, De Maeyer, M, Rendon, A, Gomez, K, Erber, W N, Mumford, A D, Nurden, P, Stirrups, K, Bradley, J R, Lucy Raymond, F, Laffan, M A, Van Geet, C, Richardson, S & Freson, K & Ouwehand, W H 2016, ' A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies ', Science Translational Medicine, vol. 8, no. 328, 328ra30 . https://doi.org/10.1126/scitranslmed.aad7666
The Src family kinase (SFK) member SRC is a major target in drug development because it is activated in many human cancers, yet deleterious SRC germline mutations have not been reported. We used genome sequencing and Human Phenotype Ontology patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3abf3e713632f2d4f4b79dd740d7ce90
https://cris.maastrichtuniversity.nl/en/publications/798e4ad0-d6bf-4108-acbd-b347381a5789
Zobrazit plný text záznamu
9
Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort
Autor: D. J. Perry, Mary Mathias, David Keeling, Michael Laffan, Ri Liesner, Peter William Collins, J. Hanley, Russell Keenan
Publikováno v: Journal of Thrombosis and Haemostasis. 7:787-794
Background and objectives: The management of patients with severe hemophilia A and inhibitors to factor VIII (FVIII) resistant to standard immune tolerance is challenging. There have been recent case reports of the successful use of rituximab in up t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1efa9adefbbc84bde0204655f9ebe298
https://doi.org/10.1111/j.1538-7836.2009.03332.x
Zobrazit plný text záznamu
10
Guidelines for the management of patients on oral anticoagulants requiring dental surgery
Autor: T J C Noakes, D J Perry, P S Helliwell
Publikováno v: British Dental Journal. 203:389-393
The objective of these guidelines is to provide healthcare professionals, including primary care dental practitioners, with clear guidance on the management of patients on oral anticoagulants requiring dental surgery. The guidance may not be appropri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd51038ad0bac62c131005b80d7fdaf1
https://doi.org/10.1038/bdj.2007.892
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje